Researchers at Brigham and Women’s Hospital have identified a new class of small molecules that selectively shut down ...

Research by Milena Bogunovic, MD, Ph.D., associate professor of pathology, sheds light on how inflammation in the ...

Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the ...

A session on the final day of the 2024 Congress of the American Society of Preventive Cardiology explored the connections between autoimmune disease and cardiac events. Patients with autoimmune ...

The medical community increasingly recognizes chronic inflammation as a fundamental driver behind numerous health conditions, from obvious manifestations like rheumatoid arthritis and inflammatory ...

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients. New research led by ...

Using human liver samples and a mouse model of cirrhosis, researchers identified epigenetic overactivation of the inflammatory PAF–PAF-R pathway in hepatic macrophages as a key driver of liver damage.

New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia by identifying the blood cancer's reliance on a specific signaling pathway ...

ORLANDO -- Markers of inflammation varied by sex, age, and menopausal status, according to a biomarker analysis. For TNF-α, the association was seen among women regardless of age (P<0.01) and in both ...

A new review article summarizes the wide-ranging, evolving potential of devices that modulate vagus nerve activity.